Related Experiment Video
Updated: Jan 28, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Gene Expression Changes Associated with Nintedanib Treatment in Idiopathic Pulmonary Fibrosis Fibroblasts: A
Chau-Chyun Sheu1,2,3, Wei-An Chang4,5,6, Ming-Ju Tsai7,8,9
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan. sheucc@gmail.com.
Abstract:
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal interstitial lung disease. Therapeutic options for IPF remain limited. Nintedanib, a tyrosine kinase inhibitor approved for IPF treatment, is known to inhibit fibroblasts proliferation, migration and transformation to myofibroblasts. However, how nintedanib changes gene regulations in IPF has never been systematically investigated. We conducted a next-generation sequencing and bioinformatics study to evaluate the changes of mRNA and miRNA profiles in IPF fibroblasts treated with 2 µM and 4 µM nintedanib, compared to those without treatment. We identified 157 upregulated and 151 downregulated genes and used STRING and DAVID databases for analysis of protein⁻protein interactions, biological pathways, and molecular functions. We found strong protein⁻protein interactions within these dysregulated genes, mostly involved in the pathways of cell cycle and mitotic cell cycle. We also discovered 13 potential miRNA⁻mRNA interactions associated with nintedanib treatment. After validation using miRDB, TargetScan, and RT-qPCR, we identified 4 downregulated genes (DDX11, E2F1, NPTX1, and PLXNA4) which might be repressed by the upregulated hsa-miR-486-3p. According to the proposed functions of DDX11, E2F1, and PLXNA4 reported in previous studies, these gene expression changes together might contribute to decreased proliferation of fibroblasts and decreased angiogenesis in the microenvironment of IPF. Our findings need further studies to confirm.
Insights
Nintedanib, a treatment for idiopathic pulmonary fibrosis (IPF), alters gene expression in lung fibroblasts. This study reveals how nintedanib impacts mRNA and miRNA profiles, potentially inhibiting fibroblast proliferation and angiogenesis in IPF.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Bioinformatics
Background:
- Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with limited treatment options.
- Nintedanib is an approved tyrosine kinase inhibitor for IPF, known to affect fibroblast behavior.
- The precise gene regulatory mechanisms of nintedanib in IPF remain unelucidated.
Purpose of the Study:
- To systematically investigate the changes in mRNA and miRNA profiles in IPF fibroblasts upon nintedanib treatment.
- To identify specific genes and microRNAs (miRNAs) involved in nintedanib's therapeutic effects.
- To explore the molecular pathways and interactions affected by nintedanib in IPF.
Main Methods:
- Next-generation sequencing (NGS) to analyze mRNA and miRNA expression profiles.
- Bioinformatic analyses using STRING and DAVID databases for pathway and interaction analysis.
- Validation of identified miRNA-mRNA interactions using miRDB, TargetScan, and RT-qPCR.
Main Results:
- Identified 157 upregulated and 151 downregulated genes in nintedanib-treated IPF fibroblasts.
- Discovered strong protein-protein interactions among dysregulated genes, primarily in cell cycle pathways.
- Identified 4 downregulated genes (DDX11, E2F1, NPTX1, PLXNA4) potentially repressed by upregulated hsa-miR-486-3p.
Conclusions:
- Nintedanib treatment significantly alters gene expression in IPF fibroblasts.
- The identified gene expression changes, particularly involving hsa-miR-486-3p, may contribute to reduced fibroblast proliferation and angiogenesis.
- These findings provide novel insights into nintedanib's mechanism of action in IPF, warranting further investigation.
More Related Videos
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
11:04RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level
Published on: May 19, 2019
Related Concept Videos
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
What is Gene Expression?
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Cell Specific Gene Expression
Cell Specific Gene Expression
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....